Activation of rheumatoid factor (RF) B cells and somatic hypermutation outside of germinal centers in autoimmune-prone MRL/lpr mice

Annals of the New York Academy of Sciences

Volumn 987, Issue , 2003, Pages 38-50

  Shlomchik, Mark J ^a   Euler, Chad W ^a   Christensen, Sean C ^a   William, Jacqueline ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibody; Autoimmunity; Immunoglobulin V gene; Rheumatoid factor; Somatic hypermutation; Systemic lupus erythematosus

Indexed keywords

AUTOANTIGEN; IMMUNOGLOBULIN G2A; RHEUMATOID FACTOR;

AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CELL SELECTION; CONFERENCE PAPER; GERMINAL CENTER; IMMUNOLOGICAL TOLERANCE; MOUSE STRAIN; NONHUMAN; REGULATORY MECHANISM; SOMATIC HYPERMUTATION;

MUS MUSCULUS;

EID: 0038579720     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb06031.x     Document Type: Conference Paper

References (70)

1. CHAN, O.T.M., M.P. MADAIO & M.J. SHLOMCHIK. 1999. The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 169: 107-121.
2. SHLOMCHIK, M.J., J. CRAFT & M.J. MAMULA. 2001. From T to B and back again: positive feedback in systemic autoimmune disease. Nature Rev. Immunol. 1: 147-153.
3. RUSSELL, D.M., Z. DEMBIC, G. MORAHAN, et al. 1991. Peripheral deletion of self-reactive B cells. Nature 354: 308-311.
4. TIEGS, S.L., D.M. RUSSELL & D. NEMAZEE. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177: 1009-1020.
5. NEMAZEE, D.A. & K. BURKI. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class-I antibody genes. Nature 337: 562-566.
6. GOODNOW, C.C., J. CROSBIE, S. ADELSTEIN, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676-682.
7. GOODNOW, C.C., R.A. BRINK & A.E. ADAMS. 1991. Breakdown of self-tolerance in anergic B lymphocytes. Nature 352: 532-536.
8. BASTEN, A., R. BRINK, E. ADAMS, et al. 1991. Self tolerance in the B-cell repertoire. Immunol. Rev. 122: 5-19.
9. RATHMELL, J.C., M.P. COOKE, W.Y. HO, et al. 1995. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376: 181-184.
10. RUBIO, C.F., J. KENCH, D.M. RUSSELL, et al. 1996. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice beating autoantibody transgenes. J. Immunol. 157: 65-71.
11. NOSSAL, G.J.V. 1988. Somatic mutations in B lymphocytes: new perspectives in tolerance research. Immunol. Cell Biol. 66:105-110.
12. GOODNOW, C.C., S. ADELSTEIN & A. BASTEN. 1990. The need for central and peripheral tolerance in the B cell repertoire. Science 248: 1373-1379.
13. NOSSAL, G.J.V. 1994. Negative selection of lymphocytes. Cell 76: 229-239.
14. PULENDRAN, B., G. KANNOURAKIS, S. NOURI, et al. 1995. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 375:331-334.
15. SHOKAT, K.M. & C.C. GOODNOW. 1995. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 375: 334-338.
16. TAN, E.M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44: 93-151.
17. KARSH, J., S.P. HALBERT, M. ANKEN, et al. 1982. Anti-DNA, anti-deoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjogren's syndrome and rheumatoid arthritis. Int. Arch. Allergy Appl. Immunol. 68: 60-69.
18. ROSEN, A., R.L. CASCIOLA & J. AHEARN. 1995. Novel packages of viral and self-antigens are generated during apoptosis. J. Exp. Med. 181: 1557-1561.
19. CASCIOLA-ROSEN, L., F. ANDRADE, D. ULANET, et al. 1999. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J. Exp. Med. 190: 815-826.
20. ERIKSON, J., M.Z. RADIC, S.A. CAMPER, et al. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349: 331-334.
21. GAY, D., T. SAUNDERS, S. CAMPER & M. WEIGERT. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177: 999-1008.
22. CHEN, C., M.Z. RADIC, J. ERIKSON, et al. 1994. Deletion and editing of B cells that express antibodies to DNA. J. Immunol. 152: 1970-1982.
23. CHEN, C., Z. NAGY, M.Z. RADIC, et al. 1995. The site and stage of anti-DNA B-cell deletion. Nature 373: 252-255.
24. PEWZNER-JUNG, Y., D. FRIEDMANN, E. SONODA, et al. 1998. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain. J. Immunol. 161: 4634-4645.
25. SANTULLI-MAROTTO, S., M.W. RETTER, R. GEE, et al. 1998. Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity 8: 209-219.
26. SHLOMCHIK, M.J., D. ZHARHARY, S. CAMPER, et al. 1993. A rheumatoid factor transgenic mouse model of autoantibody regulation. Int. Immunol. 5: 1329-1341.
27. HANNUM, L.G., D. NI, A.M. HABERMAN, et al. 1996. A disease-related RF autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J. Exp. Med. 184: 1269-1278.
28. WANG, H. & M.J. SHLOMCHIK. 1997. High affinity rheumatoid factor transgenic B cells are eliminated in normal mice. J. Immunol. 159: 1125-1134.
29. WANG, H.W. & M.J. SHLOMCHIK. 1998. Maternal Ig mediates neonatal tolerance in rheumatoid factor transgenic mice but tolerance breaks down in adult mice. J. Immunol. 160: 2263-2271.
30. WANG, H. & M.J. SHLOMCHIK. 1999. Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J. Exp. Med. 190: 639-649.
31. SOBEL, E.S., T. KATAGIRI, K. KATAGIRI, et al. 1991. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 173: 1441-1449.
32. HALPERN, M.D., C.L. FISHER, P.L. COHEN & R.A. EISENBERG. 1992. Influence of the Ig H chain locus on autoantibody production in autoimmune mice. J. Immunol. 149: 3735-3740.
33. WARREN, R.W., D.M. SAILSTAD & D.S. PISETSKY. 1984. Monoclonal rheumatoid factors from B6-lpr/lpr mice. Clin. Exp. Immunol. 58: 731-736.
34. WARREN, R.W., D.M. SAILSTAD, S.A. CASTER & D.S. PISETSKY. 1984. Specificity analysis of monoclonal anti-DNA antibodies from B6-lpr/lpr mice. Arthritis Rheum. 27: 545-551.
35. WILLIAM, J., C. EULER, S. CHRISTENSEN & M.J. SHLOMCHIK. 2002. Somatic hypermutation outside of GCs in autoantibody responses. Science 297: 2066-2070.
36. SHLOMCHIK, M.J., A. MARSHAK-ROTHSTEIN, C.B. WOLFOWICZ, et al. 1987. The role of clonal selection and somatic mutation in autoimmunity. Nature 328: 805.
37. SHLOMCHIK, M.J., A.H. AUCOIN, D.S. PISETSKY & M.G. WEIGERT. 1987. Structure and function of anti-DNA antibodies derived from a single autoimmune mouse. Proc. Natl. Acad. Sci. USA 84: 9150-9154.
38. SHLOMCHIK, M.J., M.A. MASCELLI, H. SHAN, et al. 1990. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171: 265.
39. RADIC, M.Z., M.A. MASCELLI, J. ERIKSON, et al. 1989. Structural patterns in anti-DNA antibodies from MRL/lpr mice. Cold Spring Harbor Symp. Quant. Biol. 54: 933-946.
40. TILLMAN, D.M., N.T. JOU, R.J. HILL & T.N. MARION. 1992. Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice. J. Exp. Med. 176: 761-779.
41. LOSMAN, M.J., T.M. FASY, K.E. NOVICK & M. MONESTIER 1992. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp-+/+ mouse: oligoclonality of the antibody response and recognition of a determinant composed for histones H2A, H2B, and DNA. J. Immunol. 148: 1561-1569.
42. MONESTIER, M. 1991. Variable region genes of anti-histone autoantibodies from a MRL/Mp-lpr/lpr mouse. Eur. J. Immunol. 21: 1725-1731.
43. WINKLER, T.H., H. FEHR & J.R. KALDEN. 1992. Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur. J. Immunol. 22: 1719-1728.
44. RANDEN, I., D. BROWN, K.M. THOMPSON, et al. 1992. Clonally related IgM rheumatoid factors undergo affinity maturation in the rheumatoid synovial tissue. J. Immunol. 148: 3296-3301.
45. THOMPSON, K.M., M. BORRETZEN, I. RANDEN, et al. 1996. V-gene repertoire and hypermutation of rheumatoid factors produced in rheumatoid synovial inflammation and immunized healthy donors. Ann. N.Y. Acad. Sci. 764: 440-449.
46. WITHRINGTON, R.H., I. TEITSSON, H. VALDIMARSSON & M.H. SEIFERT. 1984. Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity. Ann. Rheum. Dis. 43: 679-685.
47. WERNICK, R., J.J. LOSPALLUTO, C.W. FINK & M. ZIFF. 1981. Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. Arthritis Rheum. 24: 1501-1511.
48. IZUI, S., M. ABDELMOULA, Y. GYOTOKU, et al. 1984. IgG rheumatoid factors and cryoglobulins in mice bearing the mutant gene lpr (lymphroliferation). Rheumatol. Int. 4(Suppl): 45-48.
49. THEOFILOPOULOS, A.N. & F.J. DIXON. 1985. Murine models of systemic lupus erthematosus. Adv. Immunol. 37: 269-390.
50. HANG, L., A.N. THEOFILOPOULOS & F.J. DIXON. 1982. A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J. Exp. Med. 155: 1690-1701.
51. YOUINOU, P.Y., J.W. MORROW, A.W.F. LETTIN, et al. 1984. Specificity of plasma cells in the rheumatoid synovium. Scand. J. Immunol. 20: 307-315.
52. HOWARD, T.W., M.J. IANNINI, J.J. BURGE & J.T. DAVIS. 1991. Rheumatoid factor, cryoglobulinemia, anti-DNA, and renal disease in patients with systemic lupus erythematosus. J. Rheumatol. 18: 826-830.
53. VAN SNICK, J. & P. COULIE. 1983. Rheumatoid factors and secondary immune responses in the mouse. I. Frequent occurrence of hybridomas secreting IgM anti-IgG1 autoantibodies after immunization with protein antigens. Eur. J. Immunol. 13: 890-894.
54. NEMAZEE, D. & V. SATO. 1983. Induction of rheumatoid factors in the mouse. Regulated production of autoantibody in secondary humoral response. J. Exp. Med. 158: 529-545.
55. WELCH, M.J., S. FONG, J. VAUGHAN & D. CARSON. 1983. Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin. Exp. Immunol. 51: 299-304.
56. DJAVAD, N., S. BAS, X. Sin, et al. 1996. Comparison of rheumatoid factors of rheumatoid arthritis patients, of individuals with mycobacterial infections and of normal controls: evidence for maturation in the absence of an autoimmune response. Eur. J. Immunol. 26: 2480-2486.
57. JACOB, J., R. KASSIR & G. KELSOE. 1991. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell population. J. Exp. Med. 173: 1165-1175.
58. LIU, Y.J., J. ZHANG, P.J. LANE, et al. 1991. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur. J. Immunol. 21: 2951-2962.
59. MATSUMOTO, M., S.F. LO, C.J.L. CARRUTHERS, et al. 1996. Affinity maturation without germinal centres in lymphotoxin-α-deficient mice. Nature 382: 462-466.
60. FU, Y.-X., G. HUANG, M. MATSUMOTO, et al. 1997. Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node. Proc. Natl. Acad. Sci. USA 94: 5739-5743.
61. KONI, P.A., R. SACCA, P. LAWTON, et al. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 6: 491-500.
62. WANG, Y., G. HUANG, J. WANG, et al. 2000. Antigen persistence is required for somatic mutation and affinity maturation of immunoglobulin. Eur. J. Immunol. 30: 2226-2234.
63. WELLER, S., A. FAILI, C. GARCIA, et al. 2001. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl. Acad. Sci. USA 98: 1166-1170.
64. SMITH, K.G., G.J. NOSSAL & D.M. TARLINTON. 1995. Fas is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. Proc. Natl. Acad. Sci. USA 92: 11628-11632.
65. TAKAHASHI, Y., H. OHTA & T. TAKEMORI. 2001. Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. Immunity 14: 181-192.
66. KALLBERG, E., S. JAINANDUNSING, D. GRAY & T. LEANDERSON. 1996. Somatic mutation of immunoglobulin V genes in vitro. Science 271: 1285-1289.
67. JACOB, J. & G. KELSOE. 1992. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J. Exp. Med. 176: 679-687.
68. GARCIA DE VINUESA, C., A. GULBRANSON-JUDGE, M. KHAN, et al. 1999. Dendritic cells associated with plasmablast survival. Eur. J. Immunol. 29: 3712-3721.
69. LEADBETTER, E.A., A.M. HOHLBAUM, I.R. RIFKIN, et al. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
70. HEMMI, H., O. TAKEUCHI, T. KAWAI, et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.